---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-054266"
form_type: "8-K"
ticker: "OMDA"
cik: "0001611115"
company_name: "Omada Health, Inc."
filed_at: "2026-08-06T20:02:04+00:00"
generated_at: "2026-08-06T20:03:09.241886+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Omada Health Q2 revenue $88M (+43% YoY), net income $5M; CEO transition to Executive Chair in 2027

## Summary
- Revenue $88M, up 43% YoY; gross margin 73% (record), up from 66% in Q2 2025.
- Net income $5M vs net loss $5M in Q2 2025; adjusted EBITDA $11M vs loss $0.2M.
- CEO Sean Duffy to become Executive Chair; President Wei-Li Shao to become CEO effective Jan 1, 2027.
- Total members increased 45% YoY; trailing twelve-month revenue per member $284.
- Cash and equivalents $222M.

## SEC filing metadata
- accession: 0001628280-26-054266
- form_type: 8-K
- ticker: OMDA
- cik: 0001611115
- company_name: Omada Health, Inc.
- filed_at: 2026-08-06T20:02:04+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1611115/000162828026054266/0001628280-26-054266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1611115/000162828026054266/omda-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-054266
- JSON: https://secwatch.observer/filing/0001628280-26-054266.json
- Plain text: https://secwatch.observer/filing/0001628280-26-054266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.